Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
January 29 2015 - 8:00AM
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, today announced that it will webcast its
presentation at two upcoming investor conferences.
2015 Leerink Global Healthcare Conference
Wednesday, February 11 at 1:25 p.m. ET in New York, NY
RBC Capital Markets 2015 Global Healthcare
Conference Wednesday, February 25 at 8:00 a.m. ET in New
York, NY
The audio webcast of the presentation will be available live on
the "Investors" section of the company's website located at
www.momentapharma.com. A replay of the presentation will be posted
on the Momenta website approximately one hour after the event and
will be available for two weeks following the presentation.
About Momenta Momenta Pharmaceuticals is a
biotechnology company specializing in the detailed structural
analysis of complex drugs and is headquartered in Cambridge,
MA. Momenta is applying its technology to the development of
generic versions of complex drugs, biosimilar and potentially
interchangeable biologics, and to the discovery and development of
novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit
the website at www.momentapharma.com, which does not form a
part of this press release.
Our logo, trademarks, and service marks are the property of
Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or
service marks are property of their respective owners.
CONTACT: Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024